+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Oncolytic Virus Therapy Market Size by Application, by Type, by End User, by Geographical Scope and Forecast

  • ID: 5301561
  • Report
  • August 2020
  • Region: Global
  • 102 pages
  • Verified Market Research
1 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Genelux Corporation
  • Merck
  • Vyriad Inc.
  • MORE
Oncolytic Virus Therapy Market Size And Forecast

Oncolytic Virus Therapy Market was valued at USD 93.8 Million in 2018 and is expected to witness a growth of 25.09% from 2019-2026 and reach USD 571.4 Million by 2026.

Global Oncolytic Virus Therapy Market Overview

The growing usage of target therapy over traditional therapy, emergence of biosimilars, rising demand for mAbs, growing prevalence of cancer are the factors driving the oncolytic virus therapy market. The successful clinical trials and successful combination of oncolytic virus therapy with chemotherapy agents are expected to drive the market. The latest technological advancements in cancer treatments and the development of new therapies will foster market growth.

Global Oncolytic Virus Therapy Market: Segmentation Analysis

The Global Oncolytic Virus Therapy Market is segmented based on Application,Type, End User, and Geography.

Key Players In Oncolytic Virus Therapy Market

The Global Oncolytic Virus Therapy Market study report will provide a valuable insight with an emphasis on the global market. The major players in the market are

Amgen Inc., Merck, Vyriad Inc., Genelux Corporation

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Genelux Corporation
  • Merck
  • Vyriad Inc.
  • MORE
1 Introduction
1.1 Market Definition
1.2 Research Timelines
1.3 Assumptions
1.4 Limitations

2 Research Methodology
2.1 Data Mining
2.2 Secondary Research
2.3 Primary Research
2.4 Subject Matter Expert Advice
2.5 Quality Check
2.6 Final Review
2.7 Data Triangulation
2.8 Bottom-Up Approach
2.9 Top Down Approach
2.10 Research Flow
2.11 Data Sources

3 Executive Summary
3.1 Market Overview

4 Market Outlook
4.1 Global Oncolytic Virus Therapy Market Outlook
4.1 Market Drivers
4.1.1 Successful Clinical Trials
4.1.2 Combination With Other Cancer Treatment Therapies
4.2 Market Restraints
4.2.1 Challenge to Develop Safe and Effective Therapies
4.2.2 Challenge to Understand Oncolytic Abilities
4.3 Industry Trends
4.3.1 Limited Applications
4.3.2 On-Going Trials

5 Market
5.1 Overview

6 Competitive Landscape
6.1 Overview
6.2 Key Players
6.2.1 Merck
6.2.2 Vyriad Inc.
6.2.3 Genelux Corporation

7 Company Profiles
7.1 Amgen, Inc.
7.1.1 Company Overview
7.1.2 Company Insights
7.1.3 Segment Breakdown
7.1.4 Product Benchmarking
7.1.5 Key Developments
7.1.6 Sales
7.1.7 Key Strategy

Note: Product cover images may vary from those shown
3 of 4
  • Amgen Inc.
  • Merck
  • Vyriad Inc.
  • Genelux Corporation
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll